A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature

Teran, Santiago; Jurado, Maria Camara; Sobrino, Juan Antonio Nuñez

doi:10.1155/2021/8896254

Cited by 2 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Remiantis šia teorija, minėti komponentai išsivysto iš vienos progenitorinės pliuripotentinės kamieninės ląstelės, kuri gali įgyti vieno arba kito tipo diferenciaciją vystantis naviko karcinogenezei. Mono kloninė naviko kilmė grindžiama teigiant, kad neuroendokrininę diferenciaciją įgyja neneuroendokrininės ląstelės, adenomos ir adenokarcinomos evoliucijos metu kaupiantis specifinėms molekulinėms ir genetinėms pažaidoms [5,7,8]. Ši teorija aiškiausia kalbant apie amfikrininio tipo MiNEN, tačiau ne itin akivaizdi sudėtinių MiNEN atveju [7].…”

Section: Klinikinis Atvejisunclassified

Colorectal Neoplasm with Predominant Neuroendocrine Immunophenotype: Where does Adenocarcinoma End?

Cibulskaitė

Stulpinas

Poškus

et al. 2022

View full text Add to dashboard Cite

MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasm) is described in the 5th edition WHO classification of tumors of the digestive system as a mixed neoplasm, composed of neuroendocrine and non-neuroendocrine parts, each accounting for at least 30% of the tumor. Recently this formal criterion has been criticized based on the theory that both of these components could have a monoclonal origin and non-neuroendocrine cells develop neuroendocrinicity in the later evolutionary steps of adenocarcinoma. For this reason, the identification of pure adenocarcinoma component, that was overgrown by a more aggressive clone with neuroendocrine features, in a pathological specimen can be difficult and, in some cases, even impossible. So, it is likely that at least some of large cell neuroendocrine carcinomas follow the same pathway, a theory that is further supported by adenocarcinoma-like molecular alterations in these tumors. Precise diagnosis (which means identifying and naming each tumor component regardless of its size) is essential for a personalized treatment strategy. We present an illustrative case of a rectal neoplasm that could be classified as a poorly differentiated neuroendocrine carcinoma, but exhibits morphological heterogeneity, mucin production and has a typical KRAS mutation pointing to adenocarcinomatous origin, which makes MiNEN a more accurate diagnosis. The article discusses the key points in classification, pathogenesis, and diagnostic approach to help effectively manage such neoplasms.

show abstract

Section: Klinikinis Atvejisunclassified

Colorectal Neoplasm with Predominant Neuroendocrine Immunophenotype: Where does Adenocarcinoma End?

Cibulskaitė

Stulpinas

Poškus

et al. 2022

View full text Add to dashboard Cite

show abstract

Antineoplastics

2021

Reactions Weekly

View full text Add to dashboard Cite

Immune-mediated thyroiditis, immune-mediated cytopenia and lack of efficacy: case reportA 71-year-old man exhibited lack of efficacy during treatment with carboplatin, etoposide, paclitaxel and gemcitabine for metastatic ileocaecal mixed neuroendocrine non-neuroendocrine neoplasm (MINEN) and squamous non-small-cell lung cancer (SQ-NSCLC). He also developed immune-mediated grade 3 thyroiditis and grade 3 cytopenia during treatment with pembrolizumab for SQ-NSCLC [routes, dosages and duration of treatment to reactions onset not stated].The man was heavy smoker (116 pack years), with a past medical history of stage 1 chronic obstructive pulmonary disease (COPD). He presented to the emergency room after experiencing diffuse abdominal pain for 2 weeks. He was admitted for further evaluation. In following days, he presented worsening of intestinal obstruction symptoms for which he underwent an emergency resection with an emergency right hemicolectomy. After surgery, biopsy sampling was performed with a diagnostic bronchoscopy and body PET-scan. The body PET-scan showed hepatic lesions and para-aortic mediastinal lymphadenopathies. Histopathological results of the biopsy sampling obtained from resected colonic mass were consistent with ileocaecal MINEN with component of moderately differentiated colorectal adenocarcinoma and poorly differentiated small cell neuroendocrine carcinoma. Histopathology of the lung mass obtained for bronchoscopy biopsies revealed a lesion, which corresponded to squamous cell carcinoma (SQ-NSCLC). He was referred to the medical oncology for further consultancy. He started receiving palliative chemotherapy with carboplatin and etoposide, which was mainly directed towards NEC component of the MiNEN, in view of rapid progression at the hepatic level. Resolution of hepatic lesions was achieved through radiologic control after two cycles and no recurrence was observed at the colonic level; however, tumor progression was notable at the pulmonary mass. For optimization of treatment of SQ-NSCLC along with consideration of digestive MINEN, his chemotherapeutic regimen was switched to carboplatin and paclitaxel. Consequently, stability of SQ-NSCLC was achieved after three cycles; however, it progressed later with increase in size and metabolic activity at the lung mass. Therefore, second-line monotherapy treatment with pembrolizumab was initiated, which was directed to the SQ-NSCLC. He developed immune-mediated toxicities in form of grade 3 thyroiditis and grade 3 cytopenia [reaction outcomes not stated]. The occurrence of immune-mediated toxicities was attributed to pembrolizumab treatment.The immunotherapy with pembrolizumab was discontinued after one cycle and the man started receiving third-line chemotherapy with carboplatin and gemcitabine. However, he developed tumour progression at the CNS level, for which he received palliative holocraneal radiotherapy treatment, along with his ongoing chemotherapy. He eventually died due to disease progression at 11 months after the primary diagnosis of MINEN.

show abstract

A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature

Cited by 2 publications

References 45 publications

Colorectal Neoplasm with Predominant Neuroendocrine Immunophenotype: Where does Adenocarcinoma End?

Colorectal Neoplasm with Predominant Neuroendocrine Immunophenotype: Where does Adenocarcinoma End?

Antineoplastics

Contact Info

Product

Resources

About